Company Analysis ABIVAX Société Anonyme
1. Summary
Advantages
- The stock's return over the last year (-27.67%) is higher than the sector average (-35.53%).
- Current debt level 16.91% is below 100% and has decreased over 5 years from 80.2%.
Disadvantages
- Price (11.05 $) is higher than fair price (10.93 $)
- Dividends (0%) are below the sector average (1.72%).
- The company's current efficiency (ROE=-75.37%) is lower than the sector average (ROE=13.19%)
Similar companies
2. Share price and performance
2.1. Share price
2.2. News
2.3. Market efficiency
| ABIVAX Société Anonyme | Healthcare | Index | |
|---|---|---|---|
| 7 days | -33.3% | -0.4% | 2.6% |
| 90 days | -33.3% | -37.9% | 4.4% |
| 1 year | -27.7% | -35.5% | 25.6% |
AAVXF vs Sector: ABIVAX Société Anonyme has outperformed the "Healthcare" sector by 7.85% over the past year.
AAVXF vs Market: ABIVAX Société Anonyme has significantly underperformed the market by -53.23% over the past year.
Stable price: AAVXF is not significantly more volatile than the rest of the market on "OTC" over the last 3 months, with typical variations of +/- 5% per week.
Long period: AAVXF with weekly volatility of -0.5322% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (11.05 $) is higher than the fair price (10.93 $).
Price is higher than fair: The current price (11.05 $) is 1.1% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (0) is lower than that of the sector as a whole (31.5).
P/E vs Market: The company's P/E (0) is lower than that of the market as a whole (46.99).
4.3. P/BV
P/BV vs Sector: The company's P/BV (2.03) is lower than that of the sector as a whole (3.36).
P/BV vs Market: The company's P/BV (2.03) is higher than that of the market as a whole (-8.99).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (86.25) is higher than that of the sector as a whole (3.24).
P/S vs Market: The company's P/S indicator (86.25) is higher than that of the market as a whole (4.88).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (-1.54) is lower than that of the sector as a whole (9.95).
EV/Ebitda vs Market: The company's EV/Ebitda (-1.54) is lower than that of the market as a whole (25.22).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Rising and has grown by 58.69% over the last 5 years.
Earnings Slowdown: The last year's return (0%) is below the 5-year average return (58.69%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-52.93%).
5.4. ROE
ROE vs Sector: The company's ROE (-75.37%) is lower than that of the sector as a whole (13.19%).
ROE vs Market: The company's ROE (-75.37%) is lower than that of the market as a whole (-8.21%).
5.5. ROA
ROA vs Sector: The company's ROA (-45.17%) is lower than that of the sector as a whole (6.14%).
ROA vs Market: The company's ROA (-45.17%) is lower than that of the market as a whole (4.86%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (15.56%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (11.03%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '1.72%.
7.2. Stability and increase in payments
Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
